All Biogen Inc Sponsors for H1B Applications - 2023

Explore H1B salary data for top companies like Biogen-inc across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Biogen Inc Principal Analyst Statistical Programming Cambridge $ 128,513 / Year
Biogen Inc Director Clinical Operations Management Cambridge $ 250,500 / Year
Biogen Inc Scientist Ii Research Informatics Cambridge $ 134,191 / Year
Biogen Inc Principal Biostatistician Cambridge $ 137,748 / Year
Biogen Inc Scientist Iii Analytical Development Cambridge $ 145,413 / Year
Biogen Inc Principal Biostatistician Cambridge $ 146,983 / Year
Biogen Inc Principal Biostatistician Cambridge $ 146,983 / Year
Biogen Inc Scientist Gene Therapy Cambridge $ 141,139 / Year
Biogen Inc Engineer Iii Technical Development Cambridge $ 93,970 / Year
Biogen Inc Sr Medical Writer Cambridge $ 109,012 / Year
Biogen Inc Principal Associate Scientist Research Cambridge $ 99,981 / Year
Biogen Inc Sr Engineer I Automation Cambridge $ 115,086 / Year
Biogen Inc Sr Analyst I Planning Cambridge $ 93,970 / Year
Biogen Inc Sr Engineer Ii Mfg Sciences Cambridge $ 137,519 / Year
Biogen Inc Scientist Computational Biology Cambridge $ 115,013 / Year
Biogen Inc Principal Epidemiology Research Manager Cambridge $ 128,596 / Year
Biogen Inc Director Project Management Cambridge $ 225,500 / Year
Biogen Inc Associate Director Clinical Operations Lead Cambridge $ 192,383 / Year
Biogen Inc Senior Manager It Program Management Cambridge $ 158,086 / Year
Biogen Inc Sr It Architect Cambridge $ 158,086 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.